Press release
Cancer Biomarker Market Top Companies Study - Agilent, ARUP Laboratories, BioReference, Foundation Medicine, OncoDNA, Q² Solutions.
Cancer Biomarker Market
According to the latest research by InsightAce Analytic, the Global Cancer Biomarker Market is valued at US$ 27.3 Bn in 2023, and it is expected to reach US$ 38.9 Bn by 2031, with a CAGR of 4.7% during the forecast period of 2024-2031.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/2563
Cancer biomarkers encompass a diverse array of molecules, genes, proteins, or other substances that indicate the presence of cancer or its progression. They offer valuable insights into the biological processes underlying cancer development, enabling early detection and targeted interventions. Biomarkers hold immense potential for revolutionizing cancer care by facilitating precision medicine approaches tailored to individual patients. The cancer biomarker market is rapidly expanding due to advancements in diagnostic technologies and increasing cancer prevalence globally. Biomarkers play a significant role in the case of early detection and monitoring of cancer, driving market growth. Factors like as rising investments in research and development, growing demand for personalized medicine, and the need for non-invasive diagnostic techniques are fueling market expansion.
Additionally, the adoption of companion diagnostics and targeted therapies is boosting the market further. However, challenges such as high development costs, regulatory hurdles, and the complexity of cancer biology pose constraints. Nonetheless, the market is poised for continued growth with ongoing innovations and collaborations.
List of Prominent Players in the Cancer Biomarker Market:
• Agilent
• ARUP Laboratories
• BioReference
• Foundation Medicine
• OncoDNA
• Q² Solutions
• Thermo Fisher Scientific
• YuceBio
• Asper Biogene
• Caris Life Sciences
• CeGaT
• Genekor Medical
• Guardant Health
• Labcorp
• MedGenome
• NeoGenomics Laboratories
• Nonacus
• Oxford Gene Technology
• Personal Genome Diagnostics
• PhenoPath
• Positive Biosciences
• Quest Diagnostics
• Tempus
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2024-02
Market Dynamics:
Drivers-
The cancer biomarker market is experiencing substantial growth across various sectors. Increasing R&D efforts in cancer biomarkers are driving market growth. The research includes identifying biomarkers related to treatment resistance using genomic data, aiding in predicting post-radiation treatment responses and prognoses. This surge in research, coupled with the high cancer burden, contributes to market expansion. Additionally, strategic product developments by key market players are fueling market growth. The cancer biomarker market is witnessing a rise in product developments due to the growing significance of biomarkers in cancer diagnosis and treatment. This trend is driven by the demand for more accurate and personalized approaches to cancer management, fostering innovation in biomarker-based technologies and diagnostics.
Challenges:
Despite the prevalence of cancer globally and a growing number of patients requiring diagnostic tests, the lack of reimbursement government policies for biomarker tests in developed countries is one factor limiting the growth of biomarkers globally. Another major factor hindering the growth of the market is the high cost of diagnosis and treatment for cancer in emerging countries.
Regional Trends:
The North America cancer biomarker market is expected to register a major market share. The growing population of chronic diseases, rapid urbanization, and increasing industrialization are factors expected to proliferate the growth of green in the region. Besides, Asia-Pacific had a substantial share in the market through the adoption of new strategies by the major market players in the cancer biomarker market. Moreover, the presence of key players for market growth in the region provides the opportunity for growth of the global cancer biomarker market.
Recent Developments
• In November 2023, Agilent received FDA approval for PD-L1 IHC 22C3 pharmDx in gastric or gastroesophageal junction (GEJ) adenocarcinoma.
• In December 2022, QIAGEN received FDA approval for a companion diagnostic to Mirati Therapeutics' KRAZATI in non-small cell lung cancer.
• In November 2022, Biocare Medical, a leading provider of innovative, automated immunohistochemistry (IHC) and FISH (Fluorescent in situ hybridization) instrumentation and reagents, acquired Empire Genomics, a market leader in molecular biomarkers to aid in cancer research and diagnostics.
• In May 2022, Illumina introduced a new pan-cancer companion diagnostic to match patients with rare genetic mutations to targeted therapy.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/2563
Segmentation of Cancer Biomarker Market-
Cancer Biomarker Market- By Type of Biomarkers
• HER2
• MET
• EGFR
• PD-L1
• NTRK
• ALK
• Novel Biomarkers
• Other Biomarkers
Cancer Biomarker Market- By Type of Cancer
• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Thyroid Cancer
• Bladder Cancer
• Melanoma
• Non-Hodgkins Lymphoma
• Endometrial Cancer
• Kidney Cancer
• Leukemia
• Others
Cancer Biomarker Market- By Region
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Empower Your Decision-Making with 180 Pages Full Report @ https://www.insightaceanalytic.com/buy-report/2563
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarker Market Top Companies Study - Agilent, ARUP Laboratories, BioReference, Foundation Medicine, OncoDNA, Q² Solutions. here
News-ID: 3775166 • Views: …
More Releases from InsightAce Analytic Pvt. Ltd
3D Printed Satellite Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global 3D Printed Satellite Market- (By Component (Antenna, Bracket, Shield, Housing and Propulsion), By Satellite Mass (Nano and Microsatellite, Small Satellite, Medium and Large Satellite)), By Application, By Manufacturing Technique, By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global 3D Printed Satellite Market is valued…
TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market expect …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market- (By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market is expected to…
Health and Wellness Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Health and Wellness Market- (By Sector (Personal Care & Beauty & Anti-Aging, Nutrition & Weight Loss, Physical Activity, Wellness Tourism, Preventive & Personalized Medicine, Spa Economy, and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic, the Global Health and Wellness Market is valued at…
Blood Plasma Freezers Market expected to Witness Huge Revenue Growth to 2034
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Blood Plasma Freezers Market- (By Type (Manual Defrost, Automatic Defrost), By Application (Hospital, Laboratory), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the latest research by InsightAce Analytic, the Global Blood Plasma Freezers Market is valued at US$ 539.6 Mn in 2023, and it is expected to reach US$ 772.0 Mn…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
